# OnCo record paper-checkmate-141-ferris-nejm-2016 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-checkmate-141-ferris-nejm-2016/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-checkmate-141-ferris-nejm-2016" ;
  schema:name "CheckMate 141: nivolumab for recurrent head and neck squamous cell carcinoma after platinum"@en ;
  schema:description "Nivolumab lengthened survival compared with standard single-agent chemotherapy in head and neck cancer that had progressed within six months of platinum treatment, the first immunotherapy to improve survival in the disease."@en ;
  schema:url <https://onco.cc/key-papers/paper-checkmate-141-ferris-nejm-2016/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1602252>, <https://pubmed.ncbi.nlm.nih.gov/27718784/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1602252> ;
  schema:datePublished "2016"^^xsd:gYear ;
  schema:author "Ferris RL, Blumenschein G, Fayette J, et al." ;
  onco:cancers <https://onco.cc/cancers/recurrent-metastatic-hnscc/>, <https://onco.cc/cancers/oropharyngeal-cancer/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/> ;
  onco:trials <https://onco.cc/trials/checkmate-141/> ;
  onco:journals <https://onco.cc/journals/nejm/> .